Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Exelixis, Inc. (NASDAQ:EXEL) reiterated its slate of activities in conjunction with the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 31-June 4, 2013, in Chicago, Illinois. Clinical data from cabozantinib will be the subject of nine separate data presentations, including one oral presentation, one poster discussion, and seven general poster presentations.
Help employers find you! Check out all the jobs and post your resume.
